These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 3363046

  • 41. Increased urinary-free cortisol outputs in diabetic patients.
    Roy MS, Roy A, Brown S.
    J Diabetes Complications; 1998; 12(1):24-7. PubMed ID: 9442811
    [Abstract] [Full Text] [Related]

  • 42. Noradrenergic function and hypothalamic-pituitary-adrenal axis activity in adolescents with major depressive disorder.
    de Villiers AS, Russell VA, Carstens ME, Searson JA, van Zyl AM, Lombard CJ, Taljaard JJ.
    Psychiatry Res; 1989 Feb; 27(2):101-9. PubMed ID: 2710859
    [Abstract] [Full Text] [Related]

  • 43. Hypothalamic-pituitary-adrenal axis dysregulation among diabetic outpatients.
    Roy M, Collier B, Roy A.
    Psychiatry Res; 1990 Jan; 31(1):31-7. PubMed ID: 2156275
    [Abstract] [Full Text] [Related]

  • 44. Diurnal excretion of urinary cortisol, cortisone, and cortisol metabolites in chronic fatigue syndrome.
    Jerjes WK, Peters TJ, Taylor NF, Wood PJ, Wessely S, Cleare AJ.
    J Psychosom Res; 2006 Feb; 60(2):145-53. PubMed ID: 16439267
    [Abstract] [Full Text] [Related]

  • 45. Urinary excretion of free tyramine and of norepinephrine and its metabolites in unipolar depressed patients.
    Roy A, Linnoila M, Karoum F, Pickar D.
    Biol Psychiatry; 1986 Feb; 21(2):221-4. PubMed ID: 3947699
    [No Abstract] [Full Text] [Related]

  • 46. Reduced cortisol latency in depressive illness.
    Jarrett DB, Coble PA, Kupfer DJ.
    Arch Gen Psychiatry; 1983 May; 40(5):506-11. PubMed ID: 6838331
    [Abstract] [Full Text] [Related]

  • 47. Weight loss, cortisol levels, and dexamethasone suppression in major depressive disorder.
    Casper RC, Swann AC, Stokes PE, Chang S, Katz MM, Garver D.
    Acta Psychiatr Scand; 1987 Mar; 75(3):243-50. PubMed ID: 3473911
    [Abstract] [Full Text] [Related]

  • 48. Cerebrospinal fluid corticotropin-releasing hormone in depression: relationship to noradrenergic function.
    Roy A, Pickar D, Linnoila M, Chrousos GP, Gold PW.
    Psychiatry Res; 1987 Mar; 20(3):229-37. PubMed ID: 3495811
    [Abstract] [Full Text] [Related]

  • 49. Impaired lymphocyte stimulation by mitogens in severely depressed patients. A complex interface with HPA-axis hyperfunction, noradrenergic activity and the ageing process.
    Maes M, Bosmans E, Suy E, Minner B, Raus J.
    Br J Psychiatry; 1989 Dec; 155():793-8. PubMed ID: 2620206
    [Abstract] [Full Text] [Related]

  • 50. Pretreatment DST and hypothalamic-pituitary-adrenocortical function in depressed patients and comparison groups. A multicenter study.
    Stokes PE, Stoll PM, Koslow SH, Maas JW, Davis JM, Swann AC, Robins E.
    Arch Gen Psychiatry; 1984 Mar; 41(3):257-67. PubMed ID: 6367690
    [Abstract] [Full Text] [Related]

  • 51. High correlations of norepinephrine, dopamine, and epinephrine and their major metabolite excretion rates.
    Linnoila M, Oliver J, Adinoff B, Potter WZ.
    Arch Gen Psychiatry; 1988 Aug; 45(8):701-4. PubMed ID: 3395200
    [Abstract] [Full Text] [Related]

  • 52. Dissociative symptoms and neuroendocrine dysregulation in depression.
    Bob P, Fedor-Freybergh P, Jasova D, Bizik G, Susta M, Pavlat J, Zima T, Benakova H, Raboch J.
    Med Sci Monit; 2008 Oct; 14(10):CR499-504. PubMed ID: 18830188
    [Abstract] [Full Text] [Related]

  • 53. Clinical and magnetic resonance imaging correlates of hypothalamic-pituitary-adrenal axis function in depression and Alzheimer's disease.
    O'Brien JT, Ames D, Schweitzer I, Colman P, Desmond P, Tress B.
    Br J Psychiatry; 1996 Jun; 168(6):679-87. PubMed ID: 8773809
    [Abstract] [Full Text] [Related]

  • 54. Habituation and cortisol dysregulation in depression.
    Reus VI, Peeke HV, Miner C.
    Biol Psychiatry; 1985 Sep; 20(9):980-9. PubMed ID: 4027316
    [Abstract] [Full Text] [Related]

  • 55. Hypothalamic-pituitary-adrenal axis function in survivors of childhood acute lymphoblastic leukemia and healthy controls.
    Gordijn MS, van Litsenburg RR, Gemke RJ, Bierings MB, Hoogerbrugge PM, van de Ven PM, Heijnen CJ, Kaspers GJ.
    Psychoneuroendocrinology; 2012 Sep; 37(9):1448-56. PubMed ID: 22385687
    [Abstract] [Full Text] [Related]

  • 56. Monoamine oxidase and cortisol response in depression and schizophrenia.
    Pandey GN, Sharma RP, Janicak PG, Davis JM.
    Psychiatry Res; 1992 Oct; 44(1):1-8. PubMed ID: 1461943
    [Abstract] [Full Text] [Related]

  • 57. Urinary cortisol and cortisol metabolite excretion in chronic fatigue syndrome.
    Jerjes WK, Taylor NF, Peters TJ, Wessely S, Cleare AJ.
    Psychosom Med; 2006 Oct; 68(4):578-82. PubMed ID: 16868267
    [Abstract] [Full Text] [Related]

  • 58. Increased pituitary and adrenal reactivity in premenopausal women with posttraumatic stress disorder.
    Rasmusson AM, Lipschitz DS, Wang S, Hu S, Vojvoda D, Bremner JD, Southwick SM, Charney DS.
    Biol Psychiatry; 2001 Dec 15; 50(12):965-77. PubMed ID: 11750893
    [Abstract] [Full Text] [Related]

  • 59. Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research.
    Stetler C, Miller GE.
    Psychosom Med; 2011 Dec 15; 73(2):114-26. PubMed ID: 21257974
    [Abstract] [Full Text] [Related]

  • 60. Opioid regulation of hypothalamic-pituitary-adrenal function in depression.
    Zis AP, Haskett RF, Albala AA, Carroll BJ, Lohr NE.
    Arch Gen Psychiatry; 1985 Apr 15; 42(4):383-6. PubMed ID: 3977556
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.